Noguchi T, Chin K, Ohi M, Kita H, Otsuka N, Tsuboi T, Satoh M, Nakai A, Kuno K, Nagata K
Department of Clinical Physiology, Chest Disease Research Institute, Kyoto University, Sakyo-ku, Japan.
Am J Respir Crit Care Med. 1997 Apr;155(4):1316-22. doi: 10.1164/ajrccm.155.4.9105073.
Patients with obstructive sleep apnea syndrome (OSAS) suffer from stresses related to repetitive apneas during sleep. To examine whether the level of 72 kDa heat shock protein (HSP72) increases during sleep, 11 OSAS patients (apnea-hypopnea index: 63.5 +/- 36.1, mean +/- SD) underwent polysomnography and their peripheral blood mononuclear cells (PBMC) were isolated before, during, and after sleep. HSP72 level was determined by Western blotting and hsp72 mRNA level was quantified by Northern blotting. Nine normal subjects without OSAS were examined as normal controls. HSP72 level decreased progressively during sleep and its level at 8:00 A.M. was 78.0 +/- 17.5% of that at 8:00 P.M. (p < 0.01). No such decrease was seen in normal subjects. When OSAS patients received nasal continuous positive airway pressure (NCPAP) therapy, HSP72 level did not decrease significantly. In untreated OSAS patients, hsp72 mRNA level decreased during sleep (p < 0.01). When OSAS patients were treated with NCPAP therapy, the decrease in hsp72 mRNA level was not observed. HSP72 level before sleep in OSAS patients was higher than that in normal subjects (p < 0.01). We concluded that repetitive apneas caused high HSP72 level before sleep in OSAS patients and that NCPAP therapy had significant effect on HSP72 levels during sleep.
阻塞性睡眠呼吸暂停综合征(OSAS)患者在睡眠期间会遭受与反复呼吸暂停相关的压力。为了研究72 kDa热休克蛋白(HSP72)水平在睡眠期间是否升高,11例OSAS患者(呼吸暂停低通气指数:63.5±36.1,平均值±标准差)接受了多导睡眠图检查,并在睡眠前、睡眠期间和睡眠后分离出他们的外周血单核细胞(PBMC)。通过蛋白质印迹法测定HSP72水平,通过Northern印迹法对hsp72 mRNA水平进行定量。将9名无OSAS的正常受试者作为正常对照进行检查。HSP72水平在睡眠期间逐渐下降,其在上午8:00的水平是晚上8:00水平的78.0±17.5%(p<0.01)。正常受试者未观察到这种下降。当OSAS患者接受鼻持续气道正压通气(NCPAP)治疗时,HSP72水平没有显著下降。在未经治疗的OSAS患者中,hsp72 mRNA水平在睡眠期间下降(p<0.01)。当OSAS患者接受NCPAP治疗时,未观察到hsp72 mRNA水平的下降。OSAS患者睡眠前的HSP72水平高于正常受试者(p<0.01)。我们得出结论,反复呼吸暂停导致OSAS患者睡眠前HSP72水平升高,并且NCPAP治疗对睡眠期间的HSP72水平有显著影响。